Orkla ASA (ORK) Earnings Call Transcript & Summary

February 6, 2020

Oslo Bors NO Consumer Staples Food Products earnings 53 min

Earnings Call Speaker Segments

Thomas Ljungqvist

executive
#1

…the full-year results, and he'll also provide an update on where things stand with his main priorities. After that, our CFO, Jens Staff, will walk you through the key points from the fourth quarter results that were announced earlier this morning. Then, before we open things up for Q&A, Jaan Ivar will close with some expectations for 2020. Our prepared remarks should take about 30 minutes, which ought to leave plenty of time for questions. So let's begin — please join me in welcoming our CEO, Jaan Ivar Semlitsch.

Jaan Ivar Semlitsch

executive
#2

Thanks, Thomas, and good morning, everyone—I liked the last commercial, by the way; I think it's great. It's a pleasure to see us close out this year with a strong quarter, in which we report solid progress on both the top and bottom lines. Organic growth kept ticking up, at 2% in the quarter, and reached 1.4% for the full year 2019; it's encouraging that we are beginning to recover from a weak 2018. My ambition is to push organic growth higher in the years ahead. Earnings momentum was good as well and helped deliver improved margins for the full year. Jotun maintained its strong performance in 2019, and we also made good headway on our capital agenda, cutting working capital to sales by more than 1 percentage points, which contributed positively to cash flow for the year. All in all, 2019 has been a satisfactory year, and our shareholders have also received a very good return. I am committed to delivering on our financial targets, and 2019 has been a good start. Before we dive into the quarter, I will update you on the priorities I highlighted last quarter, beginning with our reorganization and supply chain initiatives. The organizational review I initiated in Q3 is progressing as planned. My ambition is to simplify our current structure, have a leaner Corporate Center with selected centers-of-excellence, and strengthen commercial units' decision power.

Jaan Ivar Semlitsch

executive
#3

After these changes are completely in place, I anticipate they will produce efficiency gains on a run rate basis of NOK150 million to NOK200 million. Most of that will stem from redundancies throughout our whole Corporate Center and support functions. I have to say, I am impressed by the professional way my colleagues are dealing with this process. We estimate that total restructuring and project related costs will fall within a range of NOK120 million to NOK140 million, of which NOK50 million were expensed in 2019. The savings will largely be reinvested for growth and will support our plus 2021 targets. Turning to our supply chain agenda, having visited a broad range of factories and production hubs since I joined in August, it is clear that one of Orkla's strengths is striking the right balance between, on the one hand, retaining the flexibility required to be more local than our global competitors, while at the same time having more resources and more talent than our smaller local competitors. That is necessary to support our relatively broad portfolio of strong local brands, 300 local brands in total, with products tailored to their local consumer needs. From this starting point, we are making good progress on both the cost and the capital agenda.

Jaan Ivar Semlitsch

executive
#4

We've got some big, complicated projects underway — for example, our new biscuit facility in Riga — though more frequently we've been rationalizing production lines inside the existing network. We'll keep pursuing efficiencies across the supply chain, but we now expect fewer factory mergers than we previously indicated. More importantly, our overall efficiency ambitions remain unchanged, and we're on track to deliver the planned savings in line with Orkla's EBIT margin improvement target. Turning next to an update on our Care business: I'm pleased to report another quarter of positive organic growth there. At the same time, that has to be viewed against a very weak second half of 2018 and a weak start to 2019. Q4's progress came from sales growth in our largest areas, HPC and Health, partly because sales returned following the earlier de-stocking in Poland. Fundamental changes and challenges remain in these areas, and we are addressing them. The HPC market in Norway is challenging, with volumes shifting out of grocery and into other channels. Private-label is also gaining share, mainly in the Home Care category. We keep facing challenges in several of our Health categories as well, notably weight management and sports nutrition across our markets.

Jaan Ivar Semlitsch

executive
#5

Like we said in Q3, our textile business Pierre Robert had a soft quarter, and that carried over into Q4. So you might be wondering what steps we're taking and when results should start to pick up. Our efforts to improve performance in House Care UK and Care Poland have been running for a while now, and they're producing positive results. Since he took charge of Care last summer, Orkla Care CEO Atle Vidar has launched a significant turnaround program aimed at lifting performance in our biggest HPC and health areas. That program targets meaningful cost efficiencies as well as a sharper focus on growing the core profitably. It's too soon to say the trend reversed in Q4, but I'm confident the turnaround will help performance improve toward the end of the year. Now let's turn to our growth agenda. As I mentioned when we were here three months ago, I believe there's potential to accelerate organic growth, with strong innovations around our core local brands. We have an exciting pipeline ahead, and some of those products are in front of you. I'd like to highlight just a few examples: Grandiosa, one of our biggest brands and most important categories, where we hold a strong number one position in Norway.

Jaan Ivar Semlitsch

executive
#6

Still, we cannot afford to stand still—this category keeps changing, and innovation matters most. Lately we put over NOK0.5 billion into the Pizza production hub we run in Stranda, so that we can keep creating pizza with the best taste for the people who buy it. You can see one illustration of our new concept here in the portion segment: a crust that is thinner and crispier, now being rolled out in Norway. Jotun—the commercial we watched as well—is the biggest brand we have in the Care segment and delivered solid growth during 2019. Across the Nordic markets and internationally, we are broadening our lineup of sustainable Oral Care items. Jordan Green Clean blends functionality with sustainable materials, cutting resource use to a minimum and giving materials a second life. Plant-based initiatives are another significant route to fresh opportunities, and research shows that plant-based meat replacement makes up just 1% of the worldwide meat market at present, though forecasts indicate this will shift quickly. What began as something needed by consumers eating a purely vegan diet is increasingly entering the mainstream. A wider group of shoppers, myself included, opt to swap out meat multiple times each week. I would just like to add that I still eat meat.

Jaan Ivar Semlitsch

executive
#7

The Naturli and Anamma brands fit this trend perfectly—they provide tasty, convenient plant-based food that anyone can enjoy. Both hold leading positions in their respective home markets, and we're quickly broadening distribution into other countries. With a wider launch that includes Norway in 2020, the best part is that we're seeing only limited cannibalization of Orkla's existing products. Sustainability and health trends are, in our view, driving strong growth as well for our vegetarian brands such as Felix Veggie. Combined, Naturli and Anamma turned over just NOK0.5 billion in 2019, up 40% from 2018. By the end of 2021, our ambition is to surpass NOK1 billion and to establish market-leading positions in the key categories and markets we enter. Meeting that ambition will clearly be accretive to our organic growth agenda. At this point I'd like to hand over to Jens, who will take us through the Q4 figures.

Jens Staff

executive
#8

Thanks, Jaan Ivar. Let's go through the Q4 highlights. I'm happy to report a solid close to 2019, with organic growth up and better earnings. Each of our four business areas posted organic growth during the quarter. Our Foods and Confectionery & Snacks operations showed encouraging gains in both sales and earnings. Within Food Ingredients, acquisitions were the main factor behind profit growth. Orkla Care saw sales and earnings rise, though as you'll recall, that comparison is against a very weak Q4 last year. The robust performance at Jotun that we witnessed in 2019 carried on through Q4 as well. Taken together, this drove a 30% improvement in adjusted earnings per share for the quarter. The Board plans to recommend a dividend of NOK2.60 per share for 2019. As I said, every business area achieved organic growth in the quarter, totaling 2% for the Branded Consumer Goods area. The strongest advance came in Confectionery & Snacks, an improvement fueled by favorable market growth and modifications to the Sugar Tax in Norway effective the 1st of January, 2019. As you may also recall, sales took a very negative hit in Q4 2018. A favorable trend in Home & Personal Care and Health helped lift revenue in Orkla Care against the weak 2018 quarter I just mentioned.

Jens Staff

executive
#9

In Foods, the improvement came from solid expansion in the Swedish markets and for plant-based products. Orkla Food Ingredients carried on the pattern seen in earlier quarters, with modest sales growth. All told, Branded Consumer Goods revenues were up by over 8% in Q4. Beyond the organic growth I just went through, favorable currency translation effects contributed a further 3.1%, chiefly from a weaker Norwegian kroner against the Euro. Structural growth of 3.1% came from acquisitions in Foods, Care and Food Ingredients. What's more, Kotipizza was consolidated into our investment area starting in February, which added a further 2% to Group revenues. As of Q1 in 2020, we'll report Kotipizza within the Branded Consumer Goods area, in the consumer investment part. Let's turn now to profit and margin performance. Branded Consumer Goods including HQ lifted earnings by more than 11% in the quarter, and 4% — the 4.6% was underlying improvements. That advance was chiefly fueled by top-line growth from better revenue management and positive mix effects, along with favorable effects from cost improvement projects. Every business area contributed positively to the improvement, which was offset by higher HQ costs stemming from increased pension costs, plus some timing effects.

Jens Staff

executive
#10

That progress led to a 30-basis-point gain in the underlying EBIT margin on a rolling 12 month basis, driven principally by revenue management and favorable mix effects. Those gains were partially counteracted by elevated purchasing costs along with greater HQ costs, measured against an unusually low HQ cost level in 2018. Turning to advertising spend, it has remained fairly steady. Now let's review how each business area performed, and as usual, we begin with Foods. In Foods, top-line growth came largely from currency translation plus structural growth, while organic growth contributed 1.5%. Plant-based products kept growing, backed by a robust innovation program. We are seeing solid sales momentum across several of our biggest brands — particularly strong growth in Sweden. In Denmark, sales dipped somewhat because of production facility closures and lower-margin contracts we lost. Earnings improved nicely, chiefly from higher revenues but also from cost reduction programs. Pressure from weaker Swedish-Norwegian kroner and Norwegian kroner, plus elevated raw material prices, carried on through the quarter. We offset those effects by managing revenue and the portfolio more actively.

Jens Staff

executive
#11

To sum up, profitability went up or improved by 80 basis points. Now let's turn to Confectionery & Snacks. That business of ours achieved organic growth of 5% during the quarter, against a very weak quarter a year earlier. During Q4 2018, we saw a de-stocking effect in Norway, ahead of the Sugar Tax increase being reversed as from the 1st of January in 2019. Good market growth is still visible to us, particularly within the Snacks category. Profits kept rising, mainly driven by organic growth along with positive effects from cost improvement projects. Weaker profits from our Danish business offset this progress. On top of that, higher raw material prices such as cocoa and the negative real effects of currency had a negative impact. Let's turn to Orkla Care. Orkla Care delivered organic progress of 2.4%, primarily driven by growth in Home & Personal Care and in Health. Growth was higher outside Norway, where, as Jaan Ivar referred to, we see a weak trend in the grocery channel. Orkla Health Hub saw sales growth in Poland and increased export, but this has to be viewed against a relatively weak Q4 in 2018. Pierre Robert had weak sales in Norway and Sweden in the quarter.

Jens Staff

executive
#12

Profit rose 12%, and that increase was backed by advances in health in Poland, better earnings for Home & Personal Care outside Norway, plus acquisitions in House Care. The poor result at Pierre Robert clearly works the other way. Now let's move to Food Ingredients. Food Ingredients posted solid revenue and earnings gains, largely due to M&A. Revenue growth came mainly from markets beyond Scandinavia. Naturli, our plant-based brands, kept expanding at a strong pace, and we also recorded growth in frozen cakes from bakes. Earnings climbed 21%, chiefly from M&A, which likewise gives a favorable mix impact on margins. Now on to Kotipizza's results. All in all, Kotipizza delivered a solid showing in 2019. We keep seeing healthy market momentum, with like-for-like chain sales of 6% year-to-date. Sales eased a bit in Q4, yet the start to the New Year has been encouraging so far. Kotipizza achieved satisfactory earnings growth across the full year. In Q4, earnings took a hit from heavier marketing spend and certain one-off non-periodic effects. Restaurant expansion is still underway, and we opened two new Kotipizza restaurants during the quarter. Let me wrap up our Q4 financials and dig a little deeper into our Investment division and other material items.

Jens Staff

executive
#13

Within our Branded Consumer Goods segment, HQ included, we saw robust profit growth exceeding 11%. Earnings fell by minus 29% at Orkla Investments, which covers Hydro Power and Financial Investments. Hydro Power's profits dropped minus 45%, driven by reduced output volumes and weaker power prices. Financial Investments posted an adjusted EBIT of NOK21 million, versus minus NOK1 million in Q4 of last year, and that difference stems from bringing Kotipizza in from February 2019. Non-recurring items in the quarter totaled minus NOK136 million. The biggest of these were costs and severance tied to the organizational review at Orkla HQ, along with restructuring projects in Orkla Foods, Care, and Confectionery & Snacks. Associate profits rose NOK190 million versus last year, including the NOK35 million gain from selling Oslo Business Park during the quarter. Jotun closed 2019 strongly, delivering solid improvement on both the top line and the bottom line. Orkla's share of profit after tax got a positive boost from non-periodic items. Our effective tax rate for this quarter is far lower thanks to a reversal of a prior deferred tax liability. That reversal carries no cash impact this quarter. Solid momentum across our consolidated businesses plus Jotun helped lift earnings per share by 30% — that is adjusted earnings per share.

Jens Staff

executive
#14

Earnings per share as reported for the quarter were 73% above the prior year. Within our financial targets, we're aiming to bring down our relative net working capital position by 3 percentage points by the close of 2021. After working capital rose through 2018, we're now glad to see more than 1 percentage points of improvement in 2019. That frees up roughly NOK500 million in cash. This improvement, of course, fed into our strong operational cash flow for the year. We put NOK2.4 billion into our operations during 2019, which works out to roughly 5.5% of net sales. On maintenance investments, those are fairly stable at NOK1.2 billion, and that aligns with our depreciation level of about 3% of net sales. As we said last year, we keep investing more in building our future ERP platform. Our biggest expansion investments have to do with upgrading and expanding Pizza production in Stranda in Norway. We also have several other expansion projects in Food Ingredients, plus investment in a new chocolate factory in Latvia. Looking ahead, we expect CapEx to run at the level of 4% to 6% of net sales across the next three-year period.

Jens Staff

executive
#15

But looking ahead, maintenance should also stay at or under depreciation. I'm happy that we're closing out the year with robust cash flow from operations, mostly thanks to the working capital gains I mentioned. Over the course of the year, we returned NOK2.6 billion to shareholders through ordinary dividends. Our net investment in acquisitions and organic expansion came to NOK3.1 billion. We sold off assets worth a total of NOK600 million, with the biggest deals involving real estate sales and the sale of Glyngore, one of our Danish brands. At year-end, net debt including leasing stood at NOK6.6 billion, which works out to roughly one times EBITDA for the full year. So our balance sheet remains sound, and this sits comfortably within our ambition of not exceeding 2.5 times EBITDA over time. On capital allocation, our top priority is keeping an attractive and predictable dividend consistent with the policy we announced at our most recent Capital Markets Day. The Board plans to propose a dividend of NOK2.60 per share for 2019, which works out to a payout ratio of 68% based on reported earnings per share — that's at the upper end of the 50% to 70% band referenced in our dividend policy.

Jens Staff

executive
#16

Our plan is to keep putting money into our operations, both by growing them ourselves and via M&A. Across the past 4 years, we've raised the average capital employed in our Branded Consumer Goods area by 40%, mostly by way of acquisitions. Return on capital employed came in at 13.3% in 2019, and over those last 4 years it has stayed relatively flat. That wraps up my review of the quarter, so I'll hand things back to Jaan Ivar for his closing remarks.

Jaan Ivar Semlitsch

executive
#17

Thank you very much, Jens. A few closing remarks to wrap things up. As you can see, I'm happy that we're finishing this year with a solid Q4. It's also good to see working capital levels declining in 2019, as Jens noted — that gave cash flow a nice lift for the year. I'm still fully committed to hitting our existing financial targets, and 2019 has gotten us off to a good start. As we look toward the next year, moderate growth continues to be what we see across Orkla's markets. Our estimate for average market growth is a bit above 2% in 2019, and we don't expect anything material to shift as we head into 2020. There are obviously big differences between categories and markets, and we keep innovating around the key trends where we foresee stronger growth ahead. As I said at the start of the presentation — markets will likely stay challenging for our Care segment, and our turnaround initiatives are tackling that. Raw material prices rose in the latter part of 2019, and we expect that to carry over into 2020. Striking the right balance on input prices with our customers will matter in an environment where inflation is increasingly a factor. We'll now take questions from the audience here in Oslo and from those of you following along on the webcast.

Thomas Ljungqvist

executive
#18

Okay, let's begin with a question that came in online, through the webcasts. Namita Samtani from Bank of America Merrill Lynch submitted the first one. There are actually two parts to it. Since market growth during 2019 came in slightly above 2% while the Branded Consumer Goods business delivered 1.4%, wouldn't that warrant putting more investment into the business? And the second part of what she asks is whether you could share a bit more detail on active portfolio management aimed at cutting complexity, along with some possible examples. Thank you.

Jaan Ivar Semlitsch

executive
#19

I think I can begin, and Jens can chime in if anything's been left out. Yes, market growth is estimated at 2%, while our growth for the full year came in at 1.4%, so in certain categories we've lost market share. That said, we're seeing solid growth in a number of our main core categories, where we've also placed considerable emphasis on marketing and advertising spend. I'd say the market share loss is mainly tied to the Care segment in some specific categories. Looking ahead — to address the investment question, we'll keep investing in marketing, we won't be cutting back on marketing, the plans are quite the opposite, and that's also the backdrop to project future, where a large part — a large portion of the savings will be reinvested into marketing and innovation as well, to ensure we can deliver on the 2021 targets. We'll also be working very hard on our innovation pipeline, where we're seeing good progress across all business unit areas. I think that gives you a bit of the backdrop. We're not pleased that we're losing market share in some areas, and we intend to win that back.

Jaan Ivar Semlitsch

executive
#20

On the active portfolio management question, I'd say it's too early to offer any concrete examples. But as you're aware, we've set up our Consumer and Financial Investment area, and we also have our new KL member joining the board from 1st February, Kenneth Haavet, who will head that up with a smaller investment team. Still, to give one concrete example, naturally we're not pleased with how Pierre Robert has developed. Even though it accounts for just 1% of our total EBIT, we expect a substantial profit contribution from Pierre Robert. And there we'll tackle every kind of issue. But above all, the priority is the profit improvement and the turnaround program we've launched. Anything to add on that, Jens?

Jens Staff

executive
#21

I should also mention one example: regarding what you'd call portfolio management and the improved mix effects, that involves exiting what you'd call lower margin contracts and production agreements. So I don't want to give a specific example, but we have seen an example, both in the Foods area and in the Food Ingredients area. So that's also part of portfolio management. And we've also been working systematically across many business units, cutting the tail and reducing SKU counts, so that's another example.

Thomas Ljungqvist

executive
#22

Thanks.

Analyst

analyst
#23

So my question is this: last year you spent NOK3 billion on M&A, and if you were to expand — say you made the same investment, or let's put it at NOK6 billion for expansion — where, if you could just talk through how you're thinking about it, how you'd deploy that money, that would be of interest. And also, what kind — I mean, obviously you'll be looking at buying <<inaudible>> certain growth businesses; is that more of the focus? And then obviously valuation gets trickier. When you do an acquisition, how do you approach valuations?

Jaan Ivar Semlitsch

executive
#24

I can give you some context for that, drawing also on what we mentioned in Q3. Regarding our first point on the M&A strategy, the emphasis is really on the core of the business and the adjacent core, and mainly in markets where we already have operations — Nordics, Central Europe, and the other markets, South of India and so on. So the focus stays within our existing setup. That said, for Orkla Food Ingredients, we believe we are less constrained on the geographic side, since it also involves Food Ingredients, Ice Cream Ingredients, and plant-based initiatives. That gives you a broader picture of the M&A side. That said, we would never enter an M&A case in which we don't see a solid payback and a very strong business case. So no targets have been set for total M&A spend; it must be evaluated case by case. That provides a bit of background — and I think a positive development we've observed in 2019 is that our M&A portfolio, or the acquisitions, are not diluting the margins. So we see positive effects from that angle relative to our existing portfolio. I think that's a bit of the background there.

Jaan Ivar Semlitsch

executive
#25

Is there anything else you’d like to add, Jens, or does that cover the question?

Analyst

analyst
#26

For me, it seems like — when you purchase established companies whose margins exceed your own, obviously, you'd end up paying a premium for that compared with acquiring the growth business that has normal margins because it hasn't yet established itself. So any thoughts on how you approach buying a higher-margin business than yours and how you value those?

Jaan Ivar Semlitsch

executive
#27

Right. I think whether that comes through organic means or through M&A, we're clearly examining categories with growth. Yet at the same time, sometimes it will sit at a solid position within the existing category on the margin side. So I think it's hard to single out one particular case or one particular trend. But plant-based is clearly an initiative where we see good growth and good margin development, though we also invest organically there.

Jens Staff

executive
#28

I'll also add that we look at buying businesses with stronger margins. But that's both before and after synergies, so quite often we strip out a lot of synergies, particularly when we buy companies where we have a really solid fit overall, and in that setting a great deal of the value creation also comes from removing cost and lifting margins. So it has to back the Orkla value creation plan. So, as you know, there is of course a gap between price and value.

Thomas Ljungqvist

executive
#29

Okay, I'll keep going. A lot of questions are coming in through the webcast. One is from Eirik Rafdal at Carnegie, and I believe you've already answered it — it concerns how your market share has developed. I think we can skip that one now. Then the next question comes from Markus Heiberg at Kepler Cheuvreux. On your dividend — it sits inside the 15% to 17% payout range. But what's the Board's reasoning for not raising the dividend from 2018 as targeted?

Jaan Ivar Semlitsch

executive
#30

Okay, so how I see it — and the Board shares this view — is that when you look at the payout ratio, we've been paying out a fairly high dividend. Last year it came in at 80%, and this year it's 68%. So it sits inside the range, but it's on the fairly high side of the band we've communicated. And Orkla wants to deliver a predictable, steady ordinary dividend. That's really the main rationale: we've paid quite a high dividend over time now, and we're still at the upper end of the band. If you look at pace, they pay out roughly 60% of earnings per share. So in that context as well, I'd say Orkla is paying a fairly good dividend.

Thomas Ljungqvist

executive
#31

Thank you. Is there anything else from the audience, or should I keep going. It seems I can keep going. Okay. Our next question comes from Charles Eden at UBS. Jaan Ivar, you talked about your plan to push organic sales growth even higher in 2020. I'd like to get a sense of what gives you confidence that you'll achieve that. I understand you'll have comparatively easy comps in the Orkla Care division, but on the other hand, you were set to face harder comps in Confectionery & Snacks? Yes, two questions. But let's begin with that one.

Jaan Ivar Semlitsch

executive
#32

To start, I’d say there are positive indicators looking at 2019 and Q4 2019. We’ve got a strong lineup of innovations for 2020, we’ve done solid work on revenue management, and we’re seeing additional opportunities when it comes to volume. Take, for instance, how we’ll deploy our marketing and the spending behind it. So that’s encouraging. Then there’s the turnaround program in Care, which is going to require some time. Regarding Confectionery & Snacks, one thing worth noting is that we’re up against a soft quarter in 2018. So it’s important to keep that in balance. I’d add that in our core categories, where we’ve placed significant emphasis, we’ve achieved healthy growth, and that instills confidence across the entire organization. If you look at pizza specifically, we haven’t picked up share on Grandiosa, since a new competitor has entered the market. But we’ve managed to hold onto our value proposition and our revenue base on that basis, and we observe that this competitor also, well, isn’t achieving the growth they’d likely want, without getting into further specifics on that.

Thomas Ljungqvist

executive
#33

Okay, thank you. And turning to the second question: you've restated the target for full-year 2021, which is expansion of the underlying EBIT margin of at least 150 basis points. Since you're delivering only 20 basis points — which I take to be 30 basis points in reality in 2019 — and you've flagged that you expect input cost inflation to be higher in 2020, along with reinvestment of a large share of the planned restructuring savings, what will drive an average of 65 basis points per annum, or 0.6, of underlying margin expansion across the coming two years?

Jaan Ivar Semlitsch

executive
#34

Jens could likely chime in on this too, but there's really solid underlying momentum in Q4 — part of that 0.3% is also shaped by the HQ piece relative to the quarter in 2018, Q4 2018. On top of that, we're bolstering our revenue management function as part of project future, where we see that we have the tools and methodologies in place to keep working on that further. So we feel we're on the right trajectory to deliver on the 2021 target here.

Thomas Ljungqvist

executive
#35

Thanks.

Jaan Ivar Semlitsch

executive
#36

Is there anything else you'd like to add, Jens?

Jens Staff

executive
#37

Right, so historically that's how we've been able to raise prices and offset raw material inflation, and we expect variable margin to contribute in the periods ahead as well. Then, as Jaan Ivar mentioned, HQ costs last year sat below a normal level, which accounts for roughly 20 basis points. So that normalizes, and we still have traction on the top line. Naturally, we expect greater operating leverage on margin as we head into 2020. And then, again as Jaan Ivar noted, plenty of cost programs are underway.

Jaan Ivar Semlitsch

executive
#38

Also, broadly speaking, we’re seeing a trend where raw materials are going up, simply because of trade barriers, climate change and predictability. So we’re very mindful to always take that into account as we plan ahead on the revenue management side.

Thomas Ljungqvist

executive
#39

Thank you. Are there any further questions from those in the room? If not, I can carry on with the ones coming in through the webcast. Alright, I'll go ahead. Our next question comes from Markus Heiberg at Kepler Cheuvreux. Orkla Foods posted growth of 1.8% in 2019% and 1.5% in 2018 — how does that stack up against the roughly 2% market growth you estimate? You noted that raw material costs were partly offset by higher prices charged to customers — so are we seeing volume growth? Essentially there are two questions here: value versus volume growth, and how your growth in Foods compares with the market?

Jaan Ivar Semlitsch

executive
#40

I think if we begin with the value volume piece in Q4, where we're growing on volume — that applies to both Confectionery & Snacks and to Care. So it's just worth noting from a volume standpoint. That said, within the Foods Sector in particular, we're growing in a few of our main core categories where momentum looks good, and we've also done work on our tail-end, where we deliberately spent less on marketing and didn't prioritize some of those categories. So I think that ties back to what I said in my introduction about why I believe in more organic growth, because we've done very well on the revenue management side. But there's additional potential on the volume side and in gaining share in certain specific categories. And as I also mentioned within the Food Sector, we see potential with good momentum on the plant-based initiatives. I mentioned 40% growth for plant-based in 2019 — 50% actually from Anamma and roughly 30% from Naturli. And we see that trend continuing, including now as we launch into new markets. So I think that's — and then there are various elements in this, also in the international portion of our Foods business, where we see more potential.

Jaan Ivar Semlitsch

executive
#41

Your next question concerned—

Thomas Ljungqvist

executive
#42

Alright, I'll keep going then. Our next question comes from Ole Martin Westgaard at DNB. How much did the reversal of the Sugar Tax contribute at Orkla Confectionery & Snacks in 2019?

Jaan Ivar Semlitsch

executive
#43

I suppose pinning that down precisely is tough, Jens, but I'll turn it back to you for any comments.

Jens Staff

executive
#44

So the estimate for the top-line impact is roughly 1.5 percentage points — 1.5%. That's what we're estimating the effect to be for Q4 2018, and then for Q1 2019.

Thomas Ljungqvist

executive
#45

Moving to the next question: how did the yearly price talks with Norwegian retailers play out following the pricing probe by the competition authorities?

Jaan Ivar Semlitsch

executive
#46

Appreciate that question. No, I think the entire fall and everything surrounding it — I think that has actually brought us even nearer to our customers, made us more proactive, and it has fed into our innovation efforts. So we'd like to have more customers in Norway and just three customers. But we want all of them doing well, and we collaborate closely and effectively with all three. And we've reached good discussions and meetings with every one of the Norwegian retail customers; of course, once again, we want more diversity. But we work with those strawberries we have. In India, we have 100,000 customers, which is a bit different from Norway. But we've had good discussions and close collaboration. And I think it has simply made us even more proactive in this work.

Thomas Ljungqvist

executive
#47

Thanks. Are there any questions from the audience? All right. I'll keep going. The next question comes from Markus Bjerke at SEB. Would you be able to provide additional detail on organic growth for 2019? Since the plant-based business rose 40% to approximately NOK0.5 billion, what portion of the 1.4% organic growth that you achieved was contributed by the plant-based business?

Jaan Ivar Semlitsch

executive
#48

We’re still keeping in mind that the 40% growth comes off our other base, which remains small at NOK0.5 billion. So when it comes to working out the exact total impact, I don’t have that number, but it’s still fairly limited relative to the whole. Looking ahead, though, given the growth rate we’re seeing and the potential as well, we’ll have a larger impact going forward with the pipeline we see now and also with the launch of Naturli into Norway—we have high hopes and solid plans in place to deliver on that.

Thomas Ljungqvist

executive
#49

Thanks. Our next question comes from Petter Nystrom at ADG. I have two questions; the first concerns HQ costs, which came in a bit higher than in prior quarters — what should we be expecting for 2020 on that?

Jaan Ivar Semlitsch

executive
#50

Yeah, honestly, some of those HQ expenses came from pensions. So maybe you could speak to Q4 specifically, Jens, and then I’ll give the picture for 2020?

Jens Staff

executive
#51

Right, thanks for that. The effects in that quarter included a higher return on the over 12G <<inaudible>> pensions. So that was one of the reasons, and on top of that, there were some non-periodic items. That was the impact in Q4 on its own. And then we're back to what I'd call a more normal level of HQ costs now versus 2018, and going forward it should be around — right now we're looking at roughly NOK90 million per month, approximately, and then naturally we have project future, which will also have an impact going into at least the latter part of 2020.

Jaan Ivar Semlitsch

executive
#52

So we expect the future impact from that project to arrive starting in June and July of this year. But as I said in my presentation, we're also going to reinvest in the business — particularly in marketing and on the innovation side — to make sure we can deliver against the 2021 targets. And there's more work ahead on the organic growth agenda.

Thomas Ljungqvist

executive
#53

Thanks, that's great. He actually has another question too. I suppose we've still got 10 minutes left. And you're substantially below the leverage targets you set, with net debt-to-EBITDA at 0.1 as of year-end. Are you not setting any timeline for yourself when it comes to M&A before paying out bigger dividends?

Jaan Ivar Semlitsch

executive
#54

That's tough to comment on, and it's not something we'd want to get into the details of, but if we return to our M&A strategy, we'll always examine every case individually and make sure that any M&A transaction we do comes with a good return and a solid plan going forward.

Thomas Ljungqvist

executive
#55

Thanks. There was another question as well — the next one comes from Markus Heiberg about margins, and how we should think about margins going into 2020. But I believe you addressed that earlier. So there's a further question from Markus Bjerke at SEB. Could you comment on the margins in your plant-based business, ideally the level, or if not, how they compare with your BCG segments.

Jaan Ivar Semlitsch

executive
#56

Yeah.

Jens Staff

executive
#57

No. We don't get into specifics where margins are concerned. We've provided the top-line growth momentum and the basis, but at that level we never discuss margins.

Jaan Ivar Semlitsch

executive
#58

That said, I should add that the plant-based business is, of course, profitable.

Thomas Ljungqvist

executive
#59

Thanks. I believe we've covered that already. I think the final question I have here now is: how much growth did MTR see in India during 2019? <<inaudible>> Indian demand?

Jens Staff

executive
#60

I don't think we've put out the detailed growth figure for that either. Still, the expansion was pretty much in line with the markets, and they're taking positions within blended spices that have actually lifted their market share. So MTR is doing well — that's my answer.

Jaan Ivar Semlitsch

executive
#61

Beyond the main MTR portfolio, I’d like to add something. We’ve also introduced Jordan Toothbrushes in 4,000 stores across India, drawing on the MTR setup we already have in place. So a number of our strong local brands are being used for exports, and having a platform already established in India has been encouraging—on top of the existing spice business, where we see India generally as growing, not only in population but also in increased purchasing power. As a result, more and more Indians are switching from single spices to blended spices, and MTR is extremely well-positioned for this trend, since we have a very broad and good portfolio around blended spices. I didn’t answer the detailed question, but I wanted to give some flavor to MTR, where we have a very solid position in an area with 60 million people as our customer base.

Thomas Ljungqvist

executive
#62

Thank you. Is there anyone in the audience with a question? No, and that was the final one from the web as well. So with that, thank you Jaan Ivar and thank you Jens. There are just a few more things I want to mention before we finish. We’ll return with the presentation of the first quarter results on the 5th of May. The quarterly financials will be presented at that time by our new CFO, Harald Ullevoldsaeter, who takes up his position on the 1st of March. Also, don’t forget our AGM, which takes place on the 16th of April. This brings our session to a close. Thank you all for listening.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Orkla ASA transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Orkla ASA earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Orkla ASA or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.